Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
AVTE

AVTE - Aerovate Therapeutics, Inc. Stock Price, Fair Value and News

$15.26+0.04 (+0.26%)
Market Closed as of 10 Jun 2026, 04:00 pm ET

Price Targets

AVTE Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

AVTE Price Action

Last 7 days

-19.5%

Last 30 days

-32.6%

Last 90 days

20.6%

Trailing 12 Months

145.9%

AVTE RSI Chart

AVTE Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

AVTE Valuation

Market Cap

753.0M

Price/Earnings (Trailing)

-5.81

EV/EBITDA

-5.48

Price/Free Cashflow

-6.46

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

AVTE Fundamentals

AVTE Earnings

Earnings (TTM)

-129.6M

Earnings Growth (Yr)

-5.85%

Earnings Growth (Qtr)

-26.52%

AVTE Profitability

Return on Equity

-43.73%

Return on Assets

-40.58%

Free Cashflow Yield

-15.49%

AVTE Investor Care

Shares Dilution (1Y)

1242.75%

Diluted EPS (TTM)

-1.31

About Aerovate Therapeutics, Inc.

AVTE
Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
 CEO
 WEBSITEhttps://aerovatetx.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES43

Aerovate Therapeutics, Inc. Frequently Asked Questions

AVTE is the stock ticker symbol of Aerovate Therapeutics, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jun 10 2026, market cap of Aerovate Therapeutics, Inc. is 753.02 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.